Metabolic Syndrome Components and Thyroid Nodularity in an Iodine-Sufficient Euthyroid Population
Endocrinology Research and Practice · 01.06.2026 · 30 (3)
DOI: 10.5152/erp.2026.25874 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology Research and Practice, online erschienen am 01.06.2026. Verfasst von Todorovska Liljana und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Objective
The relationship between metabolic syndrome (MetS) and euthyroid nodular goiter (ENG) remains insufficiently defined. This study assesses associations between MetS, its components, and ENG in non-diabetic, iodine-sufficient individuals.
Methods
This cross-sectional, case-control, single-center study included 203 euthyroid individuals who underwent thyroid ultrasound, anthropometric, blood pressure (BP), and laboratory assessments: thyroid function, fasting plasma glucose (FPG), and serum lipids. Logistic regression and receiver operating characteristic (ROC) curve analysis were performed using SPSS (v27.0)
Results
Among participants (aged 43.48 Å} 9.15 years, 84.73% female), 103 had ENG (89.3% female), and 100 were controls (80% female), without age difference (P = .094). MetS (P = .019) and elevated systolic blood pressure (SBP) (P < .001) were significantly prevalent in ENG, which correlated with MetS (ρ = .164, P = .019) and SBP (ρ = .267, P < .001). Body mass index (ρ = .195, P = .048) and waist circumference (ρ = .213, P = .031) correlated with nodule size. MetS doubled the risk of ENG (odds ratio [OR] = 2.02; P = .021). Elevated SBP (OR, 1.068; P < .001), FPG (OR, 1.87; P = .011), and diastolic BP (OR, 1.057; P = .042) were significantly associated with ENG. Only SBP was independently associated (OR, 2.583; P = .006) with the highest, but modest discriminatory performance (cut-off 122.5 mmHg; an area under the curve [AUC], 0.648; P < .001).
Conclusion
MetS, hypertension, and FPG are related to ENG, with SBP showing the strongest, though modest, independent association, reinforcing cardiometabolic assessment in thyroid nodularity. Cite this article as: Liljana T, Avramovski, P, et al. Metabolic syndrome components and thyroid nodularity in an iodine-sufficient euthyroid population. Endocrinol Res Pract. 2026;30(3):141-147.
Zitieren
APA
Liljana, T., Petar, A., Maja, A., Jovan, T., Tanja, M., Kosta, S., Biljana, I., & Olivija, V. (2026). Metabolic Syndrome Components and Thyroid Nodularity in an Iodine-Sufficient Euthyroid Population. Endocrinology Research and Practice, 30(3). https://doi.org/10.5152/erp.2026.25874
Vancouver
Liljana T, Petar A, Maja A, Jovan T, Tanja M, Kosta S, et al. Metabolic Syndrome Components and Thyroid Nodularity in an Iodine-Sufficient Euthyroid Population. Endocrinology Research and Practice. 2026;30(3). doi:10.5152/erp.2026.25874
BibTeX
@article{Liljana2026,
author = {Liljana, Todorovska and Petar, Avramovski and Maja, Avramovska and Jovan, Todorovski and Tanja, Makazlieva and Kosta, Sotiroski and Biljana, Ilkovska and Olivija, Vaskova},
title = {Metabolic Syndrome Components and Thyroid Nodularity in an Iodine-Sufficient Euthyroid Population},
journal = {Endocrinology Research and Practice},
year = {2026},
volume = {30},
number = {3},
doi = {10.5152/erp.2026.25874}
}
EUVIMED